New ways to make sure people are adequately informed about the risks and benefits of taking part in a clinical trial can be field-tested for effectiveness as vigorously as new medical treatments themselves, a study led by a Johns Hopkins bioethicist suggests. Informed consent, a mainstay of ethical clinical trials, is the process by which potential research subjects are asked to decide whether to participate in research. The bedrock components of the process include gaining an understanding of the study's goals and benefits, as well as the risks and roles of the subjects themselves. "Many clinical researchers believe that the informed consent process and documents need to be better and that people often consent without understanding that the research is not intended to benefit them personally," says Jeremy Sugarman, professor of bioethics and medicine at the Berman Institute of Bioethics at The Johns Hopkins University. "Although numerous improvements have been suggested, no sound objective method existed to test them, leaving the process open to costly or time-consuming interventions that could ultimately have no effect," he adds. Read More
http://www.medicalnewstoday.com/articles/93839.php
IHRT is a human rights team of persons from around the world who suffer with ARD. We share a common goal of protecting ourselves and others from practices not wise for persons afflicted with ARD. We address issues surrounding ARD in a public format so that those with ARD are informed in every aspect of an issue so that they can make an informed decisions about health care.
ARD, CAPPS, Adhesions and Adhesion Related Disorder , Internal Scar Tissue, Hope for those who suffer from Adhesions
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment